首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >4EBP1/eIF4E and p70S6K/RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-oncogenes in Mice
【24h】

4EBP1/eIF4E and p70S6K/RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-oncogenes in Mice

机译:4EBP1 / eIF4E和p70S6K / RPS6轴在小鼠AKT和N-Ras原癌基因驱动的肝癌发生中起关键作用和不同作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Concomitant expression of activated forms of v-akt murine thymoma viral oncogene homolog (AKT) and Ras in mouse liver (AKT/Ras) leads to rapid tumor development through strong activation of the mammalian target of rapamycin complex 1 (mTORC1) pathway. mTORC1 functions by regulating p70S6K/ribosomal protein S6 (RPS6) and eukaryotic translation initiation factor 4E-binding protein 1/ eukaryotic translation initiation factor 4E (4EBP1/eIF4E) cascades. How these cascades contribute to hepatocarcinogenesis remains unknown. Here, we show that inhibition of the RPS6 pathway by rapamycin effectively suppressed, whereas blockade of the 4EBP1/eIF4E cascade by 4EBP1A4, an unphosphorylatable form of 4EBP1, significantly delayed, AKT/Ras-induced hepatocarcinogenesis. Combined treatment with rapamycin and 4EBP1A4 completely inhibited AKT/Ras hepatocarcinogenesis. This strong antineoplastic effect was successfully recapitulated by ablating regulatory associated protein of mTORC1, the major subunit of mTORC1, in AKT/Ras-overexpressing livers. Furthermore, we demonstrate that overexpression of eIF4E, the proto-oncogene whose activity is specifically inhibited by 4EBP1, resulted in hepatocellular carcinoma (HCC) development in cooperation with activated Ras. Mechanistically, we identified the ectonucleoside triphosphate diphosphohydrolase 5/ adenylate kinase 1/cytidine monophosphate kinase 1 axis and the mitochondrial biogenesis pathway as targets of the 4EBP1/eIF4E cascade in AKT/Ras and Ras/eIF4E livers as well as in human HCC cell lines and tissues. Conclusions: Complete inhibition of mTORC1 is required to suppress liver cancer development induced by AKT and Ras proto-oncogenes in mice. The mTORC1 effectors, RPS6 and eIF4E, play distinct roles and are both necessary for AKT/Ras hepatocarcinogenesis. These new findings might open the way for innovative therapies against human HCC. (Hepatology 2015;61:200-213)
机译:v-akt鼠胸腺瘤病毒致癌基因同源物(AKT)和Ras在小鼠肝脏中的活化形式(AKT / Ras)的伴随表达通过强烈激活雷帕霉素复合物1(mTORC1)哺乳动物靶标导致肿瘤快速发展。 mTORC1通过调节p70S6K /核糖体蛋白S6(RPS6)和真核翻译起始因子4E结合蛋白1 /真核翻译起始因子4E(4EBP1 / eIF4E)级联发挥功能。这些级联如何促进肝癌发生仍然未知。在这里,我们显示雷帕霉素对RPS6途径的抑制作用得到有效抑制,而4EBP1A4(一种不可磷酸化的4EBP1形式)对4EBP1 / eIF4E级联的阻断则明显延迟了AKT / Ras诱导的肝癌发生。雷帕霉素和4EBP1A4的联合治疗完全抑制AKT / Ras肝癌的发生。通过消灭AKT / Ras过表达的肝脏mTORC1(mTORC1的主要亚基)的调节相关蛋白,成功地重现了这种强大的抗肿瘤作用。此外,我们证明,eIF4E(其活性被4EBP1特异性抑制的原癌基因)的过表达导致肝细胞癌(HCC)与激活的Ras协同发展。从机制上讲,我们确定了胞外核苷三磷酸二磷酸水解酶5 /腺苷酸激酶1 /胞苷单磷酸激酶1轴和线粒体生物发生途径是AKT / Ras和Ras / eIF4E肝脏以及人类HCC细胞系中4EBP1 / eIF4E级联的靶标组织。结论:必须完全抑制mTORC1才能抑制小鼠AKT和Ras原癌基因诱导的肝癌发展。 mTORC1效应子RPS6和eIF4E发挥不同的作用,并且都是AKT / Ras肝癌发生所必需的。这些新发现可能为针对人类HCC的创新疗法开辟道路。 (肝病2015; 61:200-213)

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号